Biography
Dr Laura McCullagh is Chief I Pharmacist & Head of Research, National Centre for Pharmacoeconomics (NCPE), St James's Hospital, Dublin. She holds a PhD (Trinity College Dublin) for her research in Health Technology Assessment (HTA). She has led over 40 HTA evaluations; these have informed HSE drug reimbursement decision-making. Previous roles have included Associate Professor of HTA & Pharmacoeconomcis, Pharmacology & Therapeutics, School of Medicine. She has published research in international, peer-reviewed journals. She supervises PhD, MD, MSc and post-doctoral researchers. She is internal examiner to PhD and MSc candidates. She holds undergraduate and postgraduate teaching commitments. She has led development/implementation of the Annual National HTA Module, National Patient Education Programme (in collaboration with IPPOSI). She provides peer-review for heath-economics and clinical journals. Dr McCullagh is a Member of the Board of Management and Court of Examiners, MSc Pharmaceutical Medicine, Pharmacology & Therapeutics. She is a member of the National Cancer Epi Network (ICEN) which aims to enhance cancer epidemiology research and collaborations. She was a member of the Pan-European Piperska Group (2013-2017) which aims to address pharmaceutical-related, financial sustainability of healthcare systems. She was a member of the National Prostate Cancer Research Consortium (2014-2015). She was a member of the Expert Advisory Group (2015) for the HTA Assessment, National Screening Programme for Atrial Fibrillation. She was a member of the NCCP Technology Review Committee (2015-2018); the NCCP advise the HSE on reimbursement of drugs for cancer.
Publications and Further Research Outputs
Peer-Reviewed Publications
Castro, P.D., Reynolds, C.M., Kennelly, S., Geraghty, A.A., Finnigan, K., McCullagh, L., Gibney, E.R., Perrotta, C., Corish, C.A., An investigation of community-dwelling older adults' opinions about their nutritional needs and risk of malnutrition; a scoping review, Clinical Nutrition, 2021
Dominguez Castro, Patricia, Reynolds, Ciara, Bizzaro, Maria Gabriella, Kennelly, Sharon, Clyne, Barbara, Bury, Gerard, Bradley, Catriona, Finnigan, Karen, McCullagh, Laura, Murrin, Celine, Perrotta, Carla, Gibney, Eileen R, Corish, Clare A, Characteristics and determinants of high volume dispensing in long-term oral nutritional supplement users in primary care: a secondary analysis, BJGP Open, 2021, pBJGPO.2020.0131
Kennedy, Cormac, McCullagh, Laura, Adams, Roisin, Trela-Larsen, Lea, Tilson, Lesley, Barry, Michael, Estimating the Theoretical Cost Implications of Funding New Drugs Considered Not to Be Cost-Effective, Value in Health, 2021
Castro P.D., Reynolds C.M., Kennelly S., Geraghty A.A., Finnigan K., McCullagh L., Gibney E.R., Perrotta C., Corish C.A., An investigation of community-dwelling older adults' opinions about their nutritional needs and risk of malnutrition; a scoping review, Clinical Nutrition, 2021
Croke A, Moriarty F, Boland F, McCullagh L, Cardwell K, Smith SM, Clyne B., Integrating clinical pharmacists within general practice: protocol for a pilot cluster randomised controlled trial., BMJ Open, 11, (3), 2021, pe041541
Varley Á, Tilson L, Fogarty E, McCullagh L, Barry M., The Utility of a Rapid Review Evaluation Process to a National HTA Agency., PharmacoEconomics, 2021
Leahy J, Hickey C, McConnell D, Cassidy O, Trela-Larsen L, Barry M, Tilson L, McCullagh L, NCPE Review Group., Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 23, (11), 2020, p1423-1426
Reynolds, C.M., Dominguez Castro, P., Kennelly, S., Clyne, B., Bury, G., Bradley, C., Finnigan, K., McCullagh, L., Barry, M., Murrin, C., Perrotta, C., Gibney, E., Healthcare professionals" preferences for the delivery, content and structure of a malnutrition education programme: An exploratory qualitative Study, Clinical Nutrition ESPEN, 40, 2020, p465
Dominguez Castro, P., Reynolds, C., Bizzaro, G., Kennelly, S., Clyne, B., Bury, G., Bradley, C., Finnigan, K., McCullagh, L., Barry, M., Murrin, C., Perrotta, C., Gibney, E., Corish, C., Large number of prescribed central nervous system drugs and younger age predict the use of more oral nutritional supplements units, Clinical Nutrition ESPEN, 40, 2020, p496
Kennedy, C., McCullagh, L., Adams, R., Trela-Larsen, L., Tilson, L., Barry, M., PMU52 The Reliability of Budget IMPACT Predictions for Drugs with Incremental Cost Effectiveness Ratios ABOVE the Irish Threshold, Value in Health, 23, 2020, pS612
Lamrock F, McCullagh L, Tilson L, Barry M., A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland., The European journal of health economics : HEPAC : health economics in prevention and care, 21, (6), 2020, p895-901
Warren, E., Fuller, R., Mulkerrin, L., Varley, A., McCullagh, L., Barry, M., PPM5 Health Technology Assessment and Companion Diagnostics: A Review of Submissions to the Ncpe from 2012-2019, Value in Health, 23, 2020, pS687-S688
Kennedy, C., McCullagh, L., Adams, R., Trela-Larsen, L., Tilson, L., Barry, M., PMU65 Drugs with Incremental Cost Effectiveness Ratios ABOVE the Irish Threshold and Subsequent Price Negotiations, Value in Health, 23, 2020, pS613
James, O., Cardwell, K., Moriarty, F., M Smith, S., Clyne, B., Barry, M., Boland, F., Clarke, S., Finnigan, K., Daly, M., McCullagh, L., Wallace, E., Kirke, C., Bradley, C., Gallagher, P., Murphy, E., Byrne, A.M.P., Croke, A., Fahey, T., Pharmacists in general practice: A qualitative process evaluation of the General Practice Pharmacist (GPP) study, Family Practice, 37, (5), 2020, p711-718
Dominguez Castro, P., Reynolds, C., Bizzaro, M.G., Kennelly, S., Clyne, B., Bury, G., Bradley, C., Finnigan, K., McCullagh, L., Barry, M., Murrin, C., Perrotta, C., Gibney, E., Corish, C., The characteristics of long-term oral nutritional supplement users in Ireland, Clinical Nutrition ESPEN, 40, 2020, p496-497
Castro, P. Dominguez, Reynolds, C., Kennelly, S., Clyne, B., Bury, G., Bradley, C., Finnigan, K., McCullagh, L., Barry, M., Murrin, C., Perrotta, C., Gibney, E., Corish, C., "Don"t Go Near The Word Malnutrition"; A qualitative study of community healthcare professionals and patients views on the term malnutrition, Clinical Nutrition ESPEN, 40, 2020, p592
Abdelaal Ahmed Mahmoud M Alkhatip, A., Conroy, P., Hamza, M.K., Murphy, I., Purcell, A., McGuire, D., The authors reply, Critical Care Medicine, 48, (8), 2020, pE731-E732
Castro, Patricia Domínguez, Kennelly, Sharon, Clyne, Barbara, Bury, Gerard, Bradley, Catriona, Finnigan, Karen, McCullagh, Laura, Barry, Michael, Murrin, Celine, Perrotta, Carla, Villaroel, Katherine Loayza, Reynolds, Ciara, Gibney, Eileen, Corish, Clare, A preliminary qualitative study of general practitioners" views on malnutrition management and oral nutritional supplementation prescription in the community, Proceedings of the Nutrition Society, 79, (OCE2), 2020
O'Donnell H, McCullagh L, Barry M, Walsh C., The Interaction between Price Negotiations and Heterogeneity: Implications for Economic Evaluations., Medical decision making : an international journal of the Society for Medical Decision Making, 40, (2), 2020, p144-155
Gorry C, McCullagh L, Barry M., Economic Evaluation of Systemic Treatments for Advanced Melanoma: A Systematic Review., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 23, (1), 2020, p52-60
Gorry C, McCullagh L, Barry M., Transferability of Economic Evaluations of Treatments for Advanced Melanoma., PharmacoEconomics, 38, (2), 2020, p217-231
Castro, Patricia Domínguez, Kennelly, Sharon, Murrin, Celine, Bradley, Catriona, Clyne, Barbara, Bury, Gerard, Finnigan, Karen, McCullagh, Laura, Barry, Michael, Browne, Sarah, Reynolds, Ciara, Bardon, Laura, Gibney, Eileen, Corish, Clare, A preliminary qualitative study of nurses" and dietitians" views on malnutrition management and oral nutritional supplementation prescription in the community, Proceedings of the Nutrition Society, 79, (OCE2), 2020
Reynolds, C.M., Dominguez Castro, P., Bardon, L.A., Kennelly, S., Clyne, B., Bury, G., Bradley, C., Finnigan, K., McCullagh, L., Barry, M., Murrin, C., Perrotta, C., Gibney, E., Corish, C., It Takes A Village: Patient Perspectives On The Management Of Malnutrition In The Community, Clinical Nutrition ESPEN, 40, 2020, p464-465
Dominguez Castro P, Reynolds CM, Kennelly S, Clyne B, Bury G, Hanlon D, Murrin C, McCullagh L, Finnigan K, Clarke S, Browne S, Perrotta C, Gibney ER, Corish CA., General practitioners' views on malnutrition management and oral nutritional supplementation prescription in the community: A qualitative study., Clinical nutrition ESPEN, 36, 2020, p116-127
Carey, N., McCullagh, L., Barry, M., PCN6 EVALUATING THE QUALITY AND RISK OF BIAS IN OVERALL SURVIVAL OUTCOMES FROM NON-RANDOMISED CAR T-CELL THERAPY PIVOTAL TRIALS, Value in Health, 22, 2019, pS436
Gorry C, McCullagh L, Barry M, Potential Budget Impact Of Adjuvant Treatments For Stage Iii Melanoma In Ireland , ISPOR Europe, Copenhagen, Denmark, 2019, 2019
Carey, Niamh, Harte, Marie, Gorry, Claire, McCullagh, Laura, OP136 Provision Of A Chimeric Antigen Receptor T-Cell Program: A Rapid Review, International Journal of Technology Assessment in Health Care, 35, (S1), 2019, p31-31
Lee, A., Tan, S., Usher, C., Barry, M., McCullagh, L., PNS181 SUBMISSIONS TO A NATIONAL HTA AGENCY IN IRELAND: DRUGS WITH DESIGNATED ORPHAN STATUS, Value in Health, 22, 2019, pS792
Maguire, Orla, McCullagh, Laura, Usher, Cara, Barry, Michael, OP65 Pharmacoeconomic Evaluation Of Orphan Drugs: Impact Of Extra Criteria?, International Journal of Technology Assessment in Health Care, 35, (S1), 2019, p16-16
Gorry, Claire and Leahy, Joy and Lamrock, Felicity and Walsh, Cathal and White, Arthur and Barry, Michael and McCullagh, Laura, VP82 Impact of Evidence Synthesis Methods on Outcome of Economic Evaluation, International Journal of Technology Assessment in Health Care, 35, (S1), 2019, p93 - 94
Usher C, McCullagh L, Tilson L, Barry M., Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017., Pharmacoecon Open, 3, (4), 2019, p583-589
Trela-Larsen, L., Usher, C., McCullagh, L., Barry, M., Walsh, C., PCN498 REAL-WORLD EVIDENCE ON THE UTILISATION OF ABIRATERONE AND ENZALUTAMIDE IN IRELAND, Value in Health, 22, 2019, pS534
Karen Cardwell, Susan M Smith, Barbara Clyne, Laura McCullagh, Emma Wallace, Ciara Kirke, Tom Fahey, Frank Moriarty, Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study, 2019
Carey N, McCullagh L, Barry M , Evaluating The Quality And Risk Of Bias In Overall Survival Outcomes From Non-Randomised Car T-Cell Therapy Pivotal Trials , ISPOR Europe , Copenhagen, Denmark, November 2019, 2019
Gorry, C., Leahy, J., Lamrock, F., Barry, M., McCullagh, L., PCN184 ECONOMIC EVALUATION OF CHECKPOINT INHIBITORS FOR THE TREATMENT OF ADVANCED MELANOMA IN THE IRISH HEALTHCARE SETTING, Value in Health, 22, 2019, pS471-S472
McCabe, L., Moloney, D., Barry, M., Usher, C., McCullagh, L., PCN272 - ANALYSIS OF PHARMACY CLAIMS FOR HIGH COST DRUGS: LENALIDOMIDE UTILISATION AND EXPENDITURE IN IRELAND, Value in Health, 21, 2018, pS60
O'Donnell H, McCullagh L, Barry, M, Walsh. C. , Negotiating The Relationship Between Price and Volume: Implications for ICER Calculations in Heterogeneous Treatment Populations., 40th Annual Meeting of the Society for Medical Decision Making, Montréal, Québec, Canada, October 13-17, 2018, 2018
Gorry C, McCullagh L, O'Donnell H, Barrett S, Schmitz S, Barry M, Curtin K, Beausang E, Barry R, Coyne I. , Neoadjuvant Treatment for malignant and metastatic melanoma. , Cochrane Database of Systematic Reviews. , (3), 2018
Carey, N, McCullagh, L, Barry, M, Tilson, L, PRM272 - THE EUNETHTA TRANSFERABILITY TOOL: APPLICATION TO NOVEL TREATMENTS FOR RELAPSED REFRACTORY MULTIPLE MYELOMA IN THE IRISH HEALTHCARE SETTING, Value in Health, 21, 2018, pS402-S403
Cardwell K, Clyne B, Moriarty F, Wallace E, Fahey T, Boland F, McCullagh L, Clarke S, Finnigan K, Daly M , Barry M, Smith, S , Supporting prescribing in Irish primary care: Protocol for a non-randomised pilot study of a general practice pharmacist (GPP) intervention to optimise prescribing in primary care., Pilot and Feasibility Studies, 4, (122), 2018
Evelien Moorkens , Arnold G. Vulto, Isabelle Huys,.....Laura mccullagh et al, Policies for biosimilar uptake in Europe: An overview, PLOS ONE, 2017
McCullagh L, Schmitz S, Barry M, Walsh C, Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for Cancer, PharmacoEconomics, 2017
Moorkens E, Vulto AG, Huys I, Dylst P, Godman, B, Keuerleber, S Claus B, Dimitrova M McCullagh L et al, Policies for biosimilar uptake in Europe: An overview, ONE, 2017
Hickey, N, Corcoran, A, Usher, C, Barry, M, McCullagh, L, Analysis Of Pharmacy Claims For High Cost Drugs: Ruxolitinib Utilisation And Expenditure In Ireland, Value in Health, 20, (9), 2017, pA462
Corcoran A, Hickey N, Barry M, Usher C, McCullagh L, Ivacaftor for cystic fibrosis; An evaluation of real world utilisation and expenditure in the Irish Healthcare Setting., Irish Medical Journal, 110, (8), 2017
Gorry, C, Barry, M, McCullagh, L, Analysis Of Hospital Episode Statistics To Identify Hopsital Resource Use Due To Skin Cancer In Ireland, Value in Health, 20, (9), 2017, pA506
, Partial EVPI feasible as part of HTA in Ireland, PharmacoEconomics & Outcomes News, 785, (1), 2017, p25-25
Morgan RB, McCullagh L, Barry M, Daly C, The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting., 2016
Spillane S, McCullagh L, Barry M, Usher C, Analysis of Pharmacy Claims for High Cost Oncology Products: Abiraterone and Enzalutamide Usage in Mcrpc in Ireland, Value Health, 19, (7), 2016, ppA754 - A754
Ermisch M, Bucsics A, Vella Bonanno P, Arickx F, Bybau A, Bochenek T, van de Casteele M, Diogene E, Fürst J, Garuolien" K, van der Graaff M, Gulbinovi" J, Haycox A, Jones J, Joppi R, Laius O, Langner I, Martin AP, Markovic-Pekovic V, McCullagh L, Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways., 2016
McCullagh L, Barry M, The Pharmacoeconomic Evaluation Process in Ireland, PharmacoEconomics, 34, (12), 2016, p1267 - 1276
Gorry C, McCullagh M, Barry M, Drug Utilisation of Braf Inhibitors for Melanoma in Ireland, Value Health, 19, (7), 2016, ppA728 - A728
Dolan E, Schmitz S, Barry M, McCullagh L, Movement of Drugs for Cancer Through The Pharmacoeconomic Evaluation Process in Ireland: Consideration Given to The Quality of Clinical Evidence, Value Health, 2016, 19, (7), 2016, ppA757 - A757
Schmitz S, McCullagh L, Dolan E, Walsh C, The Quev Score: A Quantitative Evaluation of the Quality of Clinical Evidence in HTA, Value Health, 19, (7), 2016, ppA499 - A499
Schmitz S, McCullagh L, Adams R, Walsh C, Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland, PharmacoEconomics, 2016
O'Donnell H, McCullagh L, Barry M, The Potential Budget Impact of PCSK9 Inhibitors in Ireland, Value Health, 2016, 7, (19), 2016, ppA643 - A643
McCullagh L, Adams R, Barry M, Schmitz S, Walsh C, Evaluation Of 'Real-World' Ipilimumab Data In Ireland., Value Health, 18, (7), 2015, ppA441-A441-
Godman B, Malmström RE, Diogene E, Gray A, Jayathissa S, Timoney A, Acurcio F, Alkan A, Brzezinska A, Bucsics A, Campbell SM, Czeczot J, de Bruyn W, Eriksson I, Yusof FA, Finlayson AE, Fürst J, Garuoliene K, Guerra Júnior A, Gulbinovi, J, Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?, 2015
McCullagh LM, Tilson L, Adams R, Barry M, HTA Informed Price Negotiations: Cost Savings To The Health Payer in Ireland., 2014
O'Brien C, Fogarty E, Walsh C, Dempsey O, Barry M, Kennedy MJ, McCullagh L, The cost of the inpatient management of febrile neutropenia in cancer patients - a micro-costing study in the Irish healthcare setting. , European Journal of Cancer Care, 2014
Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Personalizing health care: feasibility and future implications., 2013
Adams R, Gray E, McCullagh L, Schmitz S, Barry M, Walsh C, Budget impact and thresholds: how are real decisions made? Expected utility or Prospect Theory, Value Health, 16, (7), 2013, ppA490 - A490
Schmitz S, McCullagh L, Adams R, Barry M, Walsh C, A retrospective analysis of drug reimbursement decisions in Ireland. A multi criteria decision analysis approach., Value Health, 2013, 16, (7), 2013, ppA465 - A465
Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs., 2013
McCullagh L, Barry M., Survival analysis used in company submissions to the National Centre for Pharmacoeconomics, Value Health, 16, (7), 2013, ppA398 - A398
McCullagh L, Barry M, Prescribing trends for dabigatran etexilate in primary care., 2012
McCullagh L, Walsh C, Barry M , Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting., PharmacoEconomics, 30, (10), 2012, p941 - 959
McCullagh L, Walsh C, Barry M, Integration of value of information into the decision making process in Ireland, Value Health, 15, (7), 2012, ppA317 - A317
McCullagh L, Usher C, Barry M, A review of the primary care prescribing of dabigatran etexilate and rivaroxaban in Ireland, Value Health, 14, (7), 2011, ppA390 - A390
McCullagh L, Walsh C, Barry M, Prioritizing further research using the expected value of perfect information: application to VTE prophylaxis post total hip replacement, Value Health, 13, (7), 2010, ppA359 - A359
McCullagh L, Tilson L, Walsh C, Barry M, Cost effectiveness of rivaroxaban and dabigatran etexilate for the prophylaxis of venous thromboembolism and associated long term compliactions post total hip replacement in Ireland, Value Health, 12, (7), 2009, ppA334 - A334
McCullagh L, Tilson L, Walsh C, Barry M, A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting., 2009
Hopkins S, Lambourne J, Farrell G, McCullagh L, Hennessy M, Clarke S, Mulcahy F, Bergin C., Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals., HIV Med. , 7, (4), 2006, p248-54.
Clarke S, Delamere S, McCullough L, Hoskins S, Bergin C, Mulcahy F, Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users, HIV Med, 4, (1), 2003, p33 - 37
Research Expertise
Description
Dr McCullagh is Chief I Pharmacist, Head of Research, National Centre for Pharmacoeconomics, St James's Hospital, Dublin. She has been the lead on over 40 Health Technology Assessment (HTA) reports on drugs for which reimbursement by the state payer (the Health Service Executive (HSE)) is sought. Each report details clinical-effectiveness, cost-effectiveness and expected budget impact of the drug under consideration. The reports inform the HSE reimbursement decision-making process. Dr McCullagh has published research undertaken in HTA, including: comparative clinical-effectiveness and cost-effectiveness of drugs, evidence synthesis (for comparative-efficacy), value-of-information analysis, multiple-criteria-decision analysis, survival analysis (of immature clinical-trial data), cost of health-care and analysis of drug utilisation, prescribing and expenditure in the real-world setting. Dr McCullagh is a co-applicant on a number of research grants. A Health Research Board (HRB) Applied-Partnership Award examined how analysis of drug utilisation and outcomes databases can inform HTA and reimbursement. A HRB RCQPS Award investigated how a GP practice-based Pharmacist Medicines Optimisation Programme supports prescribing in primary care. A HRB RCQOS Award investigated how a multi-disciplinary prescribing strategy supports prescribing of oral nutritional supplements by GPs. Previously, she was a HRB Interdisciplinary Capacity Enhancement research fellow at Trinity College Dublin. This research programme investigated novel approaches to cancer prevention, treatment and cost in conjunction with the National Cancer Registry of Ireland and the NCPE. Dr McCullagh has published in peer reviewed journals and has presented her research at European and International Conferences. She provides peer-review for a range of health economic and clinical journals. She has provided peer-review for the Innovational Research Incentive Scheme - Veni, Netherlands Organisation for Scientific Research. Dr McCullagh supervises PhD candidates, MD candidates, MSc candidates, post-doctoral researchers and undergraduate medical students.Recognition
Representations
Lead HTA Assessor, Senior Management, Head of Research, NCPE
Lead, Development & Implementation of HTA Module, National Annual Patient Education Programme in Health Innovation, EUPATI for Irish Patient Communities (in association with IPPOSI)
Member, Irish Cancer Epidemiology Network (ICEN).
Member, National Cancer Control Programme (NCCP) Technology Review Group.
Member, The Piperska Group, a pan-European collaborative aiming to address/advance pharmaceutical-related financial sustainability of healthcare systems
Member, National Prostate Cancer Research Consortium
Member, HIQA Expert Advisory Group, HTA Assessment of National Screening Programme for Atrial Fibrillation
Peer-review for European and international top-in field journals (HTA and clinical). External peer-review for the Innovational Research Incentive Scheme - Veni, Netherlands Organisation for Scientific Research.
ISPOR Europe Programme Committee Member
Awards and Honours
'Murdoch McKenzie' Prize for Highest Academic Grades in Pharmacy Undergrad Degree (1989-1991 inclusive), University of Sunderland, UK.
'Mawson Proctor' Award for Highest Academic Grades in Pharmaceutical Chemistry & Pharmacognosy (Pharmacy), University of Sunderland, UK.
'Boots' The Chemist Prize, for Highest Academic Grades in First Year of Pharmacy Undergrad Degree, University of Sunderland, UK.
Memberships
Member of The Pharmaceutical Society of Ireland.
Member of The Royal Pharmaceutical Society of Great Britain.